|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Phase I/pilot study of SU5416(semaxinib) in combination with irinotecan/bolus 5-FU/LV (IFL) in patients with metastatic colorectal cancer显示文摘 | Lockhart AC C ropp GF Berlin JD | 2006 | Am JC lin On- co2006，29，2： | 1 |
| 2 | Cancer pharmacoge -nomics:powerful tools in cancer chemotherapy and drug de-velopment显示文摘 | Lee W Lockhart AC Kim RB | 2005 | Oncologist2005，10，2： | 1 |
| 3 | Anti-angiogenic treatment of gastrointestinal malignancies显示文摘 | Salmon JS Lockhart AC Berlin J | 2005 | Cancer Invest2005，23，： | 1 |
| 4 | Phase I /pilot study of SU5416(semaxinib)in combination with irinotecan/bolus 5-FU/ LV(IFL)in patients with metastatic colorectal cancer显示文摘 | Lockhart AC Cropp GF Berlin JD | 2006 | Am J CUn Oncol2006，29，2： | 1 |
| 5 | Aflibercept in the treatment of metastatic colorectal cancer 显示文摘 | Wang TF Lockhart AC | 2012 | Clin Med Insights Oncol2012，6，1： | 1 |
| 6 | Anti-angiogenic treatment of gastrointestinal malignancies显示文摘 | Salmon JS Lockhart AC Berlin J | 2005 | Cancer Invest2005，23，8： | 1 |
| 7 | The epidermal growth factor receptor as a target for colorectal cancer therapy显示文摘 | Lockhart AC Berlin JD | 2005 | Semin Oncol2005，32，1： | 1 |
| 8 | Investigational therapies target- ing the ErbB (EGFR, HER2, HER3, HER4) family in G1 cancers显示文摘 | Desai MD Saroya BS Lockhart AC | 2013 | Expert Opin Investig Drugs2013，22，3： | 1 |
| 9 | Pharmacogenetics of ATP-binding cassette transporters in cancer and chemotherapy显示文摘 | Lockhart AC Tirona RG Kim RB | | 0，，： | 1 |
| 10 | Phase Ⅰ study of intravenous vascular endothelial growth factor trap,aflibercept,in patients with advanced solid tumors显示文摘 | Lockhart AC Rothenberg ML Dupont J | 2010 | Clin Oncol2010，28，2： | 1 |
| 11 | Anti-angiogenic treatment of gastrointestinal malignancies显示文摘 | Salmon JS Lockhart AC Berlin J | 2005 | Cancer Invest2005，23，8： | 1 |
| 12 | Phase I study of intravenous vascular endothelial growth factor trap, aflibercept, in patients with advanced solid tumors 显示文摘 | Lockhart AC Rothenberg ML Dupont J et ol | 2009 | J Clin Oneol2009，28，2： | 1 |
| 13 | Phase Ⅰ Study of intravenous vascular endothelial growth factor trap,aflibercept,in patients with advanced solid tumors显示文摘 | Lockhart AC Rothenberg ML Dupont J | 2010 | J Clin Oncol2010，28，2： | 1 |
| 14 | Phase I study of in- travenous vascular endothelial growth factor trap, afiibercept, in pa- tients with advanced solid tumors显示文摘 | Lockhart AC Rothenberg ML Dupont J | 2010 | J Clin Oncal2010，28，2： | 1 |
| 15 | Anti - angiogenic treatment of gastrointestinal malignancies 显示文摘 | Salmon JS Lockhart AC Berlin J | 2005 | Cancer Invest2005，23，8： | 1 |
| 16 | Investigational therapies targeting the ErbB (EGFR, HER2, HER3, HER4) family in GI cancers 显示文摘 | Desai MD Saroya BS Lockhart AC | 2013 | Expert Opin Investig Drugs2013，22，3： | 1 |
| 17 | The epidermal growth factor re-ceptor as a target for colorectal cancer therapy显示文摘 | Lockhart AC Berlin JD | 2005 | SeminOncol2005，32，1： | 1 |
| 18 | PhaseⅠstudy of intravenous vascular endothelial growth factor trap,aflibercept in patients with advanced solid tumors显示文摘 | Lockhart AC Rothenberg ML Dupont J | 2010 | Clin Oncol2010，28，2： | 1 |
| 19 | Overexpression ofOATP1B3 confers apoptotic resistance in colon cancer 显示文摘 | Lee W Belkhiri A Lockhart AC | 2008 | Cancer Res2008，68，10： | 1 |
| 20 | Phase I study of intravenous vascular endothelial growth factor trap, aflibercept, in patients with advanced solid tumors显示文摘 | Lockhart AC Rothenberg ML Dupont J | 2010 | J Clin Oncol2010，28，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员